Company Information

  

Address: 9704 MEDICAL CENTER DRIVE  
City: Rockville 
State: MD 
Zip Code: 20850 
Telephone: 301-251-5172 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

Except as otherwise indicated herein or as the context otherwise requires, references in this annual report on Form 10-K to "MacroGenics," the "company," "we," "us" and "our" refer to MacroGenics, Inc. and its consolidated subsidiaries. MacroGenics, the MacroGenics logo, DART(R), TRIDENTTM and the phrase "Breakthrough Biologics, Life-Changing Medicines" are our trademarks or registered trademarks. The other trademarks, trade names and service marks appearing in this report are the property of their respective owners. Overview We are a biopharmaceutical company focused on discovering and developing innovative antibody-based therapeutics designed to modulate the human immune response for the treatment of cancer.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
12/2017-0.54NAN/E
09/2017-4.50NAN/E
06/2017-4.18NAN/E
03/2017-1.89NAN/E
12/2016-1.69NAN/E
09/2016-1.57NAN/E
06/2016-1.10NAN/E
03/2016-2.93NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-0.03Total Liab/Total Assets0.20
Net Inc/Total Assets-0.05Total Liab/Inv Cap0.23
Net Inc/Inv Cap-0.06Total Liab/Comm Equity0.12
Pretax Inc/Net Sales-0.12Interest Coverage RatioNA
Net Inc/Net Sales-0.12Curr Debt/EquityNA
Cash Flow/Net Sales0.09LTD/EquityNA
SG&A/NetSales0.21Total Debt/EquityNA
Asset Utilization   Liquidity  
Net Receivables Turnover19.23Quick Ratio6.48
Inventory TurnoverNACurrent Ratio6.48
Inventory Day SalesNANet Rec/Curr Assets0.04
Net Sales/Work Cap0.58Inv/Curr AssetsNA
Net Sales/PP&E3.16  

Income Statement (Millions)

  12/31/2017 9/30/2017 6/30/2017 3/31/2017
Total Revenues(Net Sales) 152.36 1.66 1.67 2.06
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 8.40 8.40 8.38 7.46
Operating Income 104.97 -47.72 -41.18 -38.21
Interest Exp NA NA NA NA
Pretax Income 105.73 -47.04 -40.66 -37.66
Other Income 0.76 0.68 0.53 0.55
Net Income Bef Extraordinary ... NA NA NA NA
Net Income 105.73 -47.04 -40.66 -37.66

Balance Sheet (Millions)

Assets 12/31/2017 9/30/2017 6/30/2017 3/31/2017
Cash & Short Term Investments 305.12 203.65 243.66 243.10
Receivables - Total 13.64 2.19 1.99 2.09
Inventories - Total NA NA NA NA
Total Current Assets 322.30 209.47 250.11 251.01
Net Property, Plant & Equipment 49.98 30.84 23.18 17.38
Total Assets 373.88 241.85 274.85 274.72
Liabilities        
Accounts Payable 41.03 27.18 24.41 19.47
Debt in Current Liabilities NA NA NA NA
Total Current Liabilities 49.76 32.44 29.89 26.55
Long-Term Debt NA NA NA NA
Total Liabilities 74.65 52.38 43.50 40.08
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 0.37 0.37 0.37 0.35
Retained Earnings -312.34 -418.07 -371.02 -330.37
Treasury Stock NA NA NA NA
Total Stockholders' Equity 299.24 189.47 231.35 234.64
Total Liabilities and Stockholders' Equity 373.88 241.85 274.85 274.72

Cash Flow Summary (Millions)

Categories 12/31/2017 9/30/2017 6/30/2017 3/31/2017
Net Cash Provided by Operating Activities 111.85 -31.35 -30.76 -35.33
Net Cash Provided by Investing Activities 8.64 4.46 73.13 -8.36
Net Cash Provided by Financing Activities 0.36 1.15 33.73 0.11

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/201358.04-0.26-0.04
12/201447.80-38.31-1.40
12/2015100.85-20.14-0.63
12/201691.88-58.53-1.69
12/2017157.74-19.63-0.54
Growth Rates28.40----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional03/31/1813733,70280.18




Report Date : 4/16/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.